Literature DB >> 32242817

Aberrant distribution of CD3+CD56+ NKT-like cells in patients with primary Sjögren's syndrome.

Liling Zhao1, Wenwen Xu2, Zhilei Chen3, Haoze Zhang2, Shuo Zhang3, Chaofeng Lian4, Jinlei Sun4, Hua Chen5, Fengchun Zhang6.   

Abstract

OBJECTIVES: To elucidate the potential role of CD3+CD56+ NKT-like cells in the pathogenesis of primary Sjögren's syndrome (pSS).
METHODS: We enrolled pSS patients and healthy controls and examined the peripheral population, the surface chemokine receptors and the proinflammatory cytokine production of NKT-like cells by flow cytometry. The infiltration of NKT-like cells in the labial salivary gland (LSG) was examined by immunofluorescence. Serum and tissue levels of CX3CL1 were detected by Cytometric Bead Array and immunohistochemistry, respectively. The chemotaxis of NKT-like cells was examined by transwell migration assay.
RESULTS: Peripheral NKT-like cells from pSS patients were significantly lower than those from HC (3.09±2.35% vs. 5.37±4.06%, p=0.0002), which was negatively correlated with European League Against Rheumatism Sjögren's Syndrome Disease Activity index. NKT-like cells infiltrated into the LSG of pSS patients. Serum and LSG epithelial CX3CL1 levels were higher in pSS patients than those in HC, which promoted the chemotaxis of the NKT-like cells. NKT-like cells from pSS patients expressed a higher level of CD69, and secreted high level of TNF-α and IFN-γ, which was promoted by CX3CL1 in vitro.
CONCLUSIONS: NKT-like cells decreased in peripheral and infiltrated into the LSG of the pSS patients, which could be driven by CX3CL1-CX3CR1 axis. NKT-like cells might be implicated in the pathogenesis of pSS.

Entities:  

Mesh:

Year:  2020        PMID: 32242817     DOI: 10.55563/clinexprheumatol/uzzz6d

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.862


  2 in total

1.  Diminished natural killer T-like cells correlates with aggravated primary Sjögren's syndrome.

Authors:  Xinhua Zhou; Qingxiang Li; Yun Li; Jingjing Fu; Feng Sun; Yan Li; Yushu Wang; Yuan Jia; Yanna Zhang; Rulin Jia; Fanlei Hu; Yingni Li
Journal:  Clin Rheumatol       Date:  2022-01-21       Impact factor: 2.980

2.  PD-1 blockade improves the anti-tumor potency of exhausted CD3+CD56+ NKT-like cells in patients with primary hepatocellular carcinoma.

Authors:  Longxiang Tao; Shanshan Wang; Guijie Kang; Shanyue Jiang; Wenwei Yin; Lu Zong; Jing Li; Xuefu Wang
Journal:  Oncoimmunology       Date:  2021-11-09       Impact factor: 8.110

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.